Companies · Biotech
Toronto · ON, Canada · Biotech · founded 2022 · https://thealttex.com/
Diligence memoA one-page analyst read on ALT TEX — recommendation, valuation, rhythm, risks.→ALT TEX: limited disclosed financing to assess.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
ALT TEX is one of 233 Biotech companies tracked from Toronto, ON, Canada, on record since 2022. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and mid-pack by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
Biodegradable and carbon neutral textiles, engineered from food waste.
ALT TEX is a Toronto-based biomaterials startup that has developed the world’s first biodegradable and carbon neutral fabric, engineered from the world’s largest landfill contributor - food waste. Polyester alone makes up 60% of the $2.5 trillion fashion industry and is the biggest blocker preventing brands from meeting sustainability mandates. The patent-pending ALT TEX fermentation technology creates a polyester alternative that works with the existing infrastructure to supply a sustainable, high performance and cost competitive polyester replacement to fashion brands, at scale. The product solves key problems for fashion brands, consumers, and the environment: (1) Fashion brands: ALT TEX sells fabric to fashion brands, allowing them to differentiate via sustainable options (sustainable fashion growing 11% CAGR) and hit sustainability targets, without sacrificing performance or changing their current supply chain. (2) Consumer: The ALT TEX fabric is projected to be half the price vs. other specialized sustainable alternatives (due to low-cost input and scalability), meaning greater accessibility. (3) Environment: A single shirt produced with ALT TEX fabric can divert 1 kg of food waste from landfills, 9 kg of carbon emissions from the air, and 4 g of micro-plastics from our waterways. Co-founders Myra and Avneet have worked together managing teams and projects for six years, with backgrounds in serial entrepreneurship, corporate sales at Fortune 500 companies, textile manufacturing and biochemistry. To date, ALT TEX has created their first fabric prototype that’s 70% stronger than cotton, secured $1M in LOIs and raised $2.3M.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
No round amounts on record to chart.
No staged rounds to sequence.
Round size and date are reported; the stage label is inferred from round size. Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 233 companies in Biotech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 67% of sector peers (real $). Modeled value above 67% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| No rounds recorded. | |||||
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
ALT TEX is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| 10x Science | Biotech | — | — | — | same sector |
| 1849 bio | Biotech | — | — | — | same sector |
| 1910 | Biotech | — | — | — | same sector |
| 20n | Biotech | — | — | — | same sector |
| 54Gene, Inc. | Biotech | Series B | $48.3M | $598.4M | same sector |
| Abacus Bioscience Inc. | Biotech | Series A | $4.4M | $46.6M | same sector |
| Abalone Bio | Biotech | — | — | — | same sector |
| Acoustic Wave Cell Therapy, Inc. | Biotech | Series A | $20.5M | $84.9M | same sector |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| AltheaDx, Inc. | Biotechnology | Series B | $137.3M | 73% |
| Birch Biosciences We recycle plastic using engineered enzymes | Biotech | — | — | 72% |
| Carbonfact Decarbonizing the fashion industry | Climate / Cleantech | — | — | 72% |
| Altis Biosystems, Inc. | Biotechnology | Seed | $6.8M | 71% |
| Releaf Earth Turning food waste into Biochar to remove CO2 from the atmsophere | Climate / Cleantech | — | — | 71% |
| Ilex Organics, LLC | Manufacturing | Pre-Seed | $5.3M | 71% |
| AltPep Corp | Biotechnology | Series C | $837.9M | 70% |
| Biome Makers Inc. | Other Technology | Series A | $267.9M | 70% |
See where ALT TEX sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at ALT TEX, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.